Abstract: This disclosure describes a system and method for generating structured reports from video footage using artificial intelligence. The system extracts frames from video inputs, identifies and tracks objects across frames, and applies importance adjustments based on context. A Long Short-Term Memory (LSTM) network analyzes temporal patterns and integrates spatial data from feature point identification and geomapping techniques. Event detection modules identify key actions, while scene understanding and semantic segmentation provide environmental context and pixel-level detail. Outputs from these analyses are processed by a generative AI engine, specifically a large language model (LLM), to produce a coherent natural language description of the recorded events. A second LLM formats the narrative according to the template required by the organization, such as a police department, ensuring compliance with specific standards. Users can review and edit the final report through an interface before submission.

Abstract: Systems and methods for reducing health risks with respect to an infectious disease in buildings. Health data for an infectious diseases is used to determine a health risk level for building spaces and individuals in the building. An air handling action or a disinfection action is performed based on the health risk level.

Abstract: A thrombectomy apparatus includes a funnel that is secured to a distal end of a catheter. The funnel includes a braided inner layer, a braided outer layer and a reinforcing structure disposed therebetween. The reinforcing structure includes a tubular metal member and a plurality of fingers extending distally from the tubular metal member. Each finger defines two or more pockets. Each of two or more rings extend through a pocket of each of the plurality of fingers, the pockets limiting axial movement of each of the two or more rings. A tractor is adapted to extend over the outer surface of the catheter and the funnel in an un-inverted configuration and to extend in an inverted configuration through the funnel and into the lumen. An elongate member extends through the lumen and is secured to an end of the tractor disposed within the lumen.

Abstract: A thrombectomy apparatus includes a catheter having a funnel is secured to a distal end and extending distally therefrom. The funnel includes a braided inner layer, a braided outer layer, and a reinforcing structure disposed between the braided inner layer and the braided outer layer, the reinforcing structure including a plurality of arched wires extending between the braided inner layer and the braided outer layer. A tractor is adapted to extend over the outer surface of the catheter and the funnel in an un-inverted configuration and to extend in an inverted configuration through the funnel and into the lumen, the tractor adapted to invert by rolling over the distal end of the funnel when the tractor moves proximally. An elongate member extends through the lumen and is secured to an end of the tractor disposed within the lumen.

Abstract: A thrombectomy apparatus for removing a clot from a vessel includes a catheter defining a lumen extending proximally from a distal end. A funnel is secured to the distal end and extends distally therefrom, the funnel includes a braided inner layer and a braided outer layer, the braided outer layer folded over the braided inner layer and adapted to constrain the braided inner layer. A tractor is adapted to extend over an outer surface of the catheter and the funnel in an un-inverted configuration and to extend in an inverted configuration through the funnel and into the lumen, the tractor adapted to invert by rolling over the distal end of the funnel when the tractor moves proximally. A puller extends through the lumen and is secured to an end of the tractor disposed within the lumen.

Abstract: The present invention provides pharmaceutical compositions, for storage and administration, comprising an anti-human B7-H3 (“hB7-H3”) antibody (“enoblituzumab”) and buffering agents. The invention provides containers and kits comprising such pharmaceutical compositions. The invention further provides the use of such pharmaceutical compositions, containers, and kits containing enoblituzumab for the treatment of a cancer, and in certain aspects, treatment of a cancer expressing B7-H3.

Abstract: The present invention relates to Tri-Specific Binding Molecules, which are multi-chain polypeptide molecules that possess three Binding Domains and are thus capable of mediating coordinated binding to three epitopes. The Binding Domains may be selected such that the Tri-Specific Binding Molecules are capable of binding to any three different epitopes. Such epitopes may be epitopes of the same antigen or epitopes of two or three different antigens. In a preferred embodiment, one of such epitopes will be capable of binding to CD3, the second of such epitopes will be capable of binding to CD8, and the third of such epitopes will be capable of binding to an epitope of a Disease-Associated Antigen. The invention also provides a novel ROR1-binding antibody, as well as derivatives thereof and uses for such compositions.

Abstract: Described herein are intracameral implants including at least one therapeutic agent for treatment of at least one ocular condition. The implants described herein are not anchored to the ocular tissue, but rather are held in place by currents and gravity present in the anterior chamber of an eye. The implants are preferably polymeric, biodegradable and provide sustained release of at least one therapeutic agent to both the trabecular meshwork and associated ocular tissue and the fluids within the anterior chamber of an eye.

Abstract: Disclosed are antiseptic compositions for disinfecting tissues, in particular for ocular use. Methods and compositions disclosed herein include sodium chlorite, optionally in combination with a surfactant.

Abstract: A building management system (BMS) for filtering a fluid within a building is shown. The system includes one or more sensors configured to measure one or more characteristics of a first fluid within an air duct of the BMS and measure one or more characteristics of a second fluid after the second fluid has been filtered. The system further includes a pollutant management system configured to receive data from the one or more sensors and control a filtration process. The filtration process selects a filter of a plurality of filters based on at least one of a level of the one or more characteristics of the first fluid or the one or more characteristics of the second fluid.

Abstract: The present invention relates to Tri-Specific Binding Molecules, which are multi-chain polypeptide molecules that possess three Binding Domains and are thus capable of mediating coordinated binding to three epitopes. The Binding Domains may be selected such that the Tri-Specific Binding Molecules are capable of binding to any three different epitopes. Such epitopes may be epitopes of the same antigen or epitopes of two or three different antigens. In a preferred embodiment, one of such epitopes will be capable of binding to CD3, the second of such epitopes will be capable of binding to CD8, and the third of such epitopes will be capable of binding to an epitope of a Disease-Associated Antigen. The invention also provides a novel ROR1-binding antibody, as well as derivatives thereof and uses for such compositions.

Abstract: Disclosed are antiseptic compositions for disinfecting tissues, in particular for ocular use. Methods and compositions disclosed herein include sodium chlorite, optionally in combination with a surfactant.

Abstract: Container including base portion defining compartment. Base portion includes bottom panel defining bottom of compartment, front base panel defining front of compartment and extending upwardly from bottom panel. Base portion further includes back panel extending from bottom panel to define a back of compartment, and first and second side tabs extending between bottom panel, front base panel, and back panel at opposing sides thereof to define opposing sides of compartment. Container further includes lid portion including a top panel and a front lid panel. The top panel includes an opening and an access flap moveable between an opening position and a closed position defining the opening. The access flap includes a back edge, a front edge, opposing side edges, and a first and second front protrusions, respectively. Blanks for forming such a container and methods for disposing a web material are also disclosed.

Abstract: The present disclosure is provides pharmaceutical compositions, for storage and administration, comprising a human PD-1 (“hPD-1”) antibody (“retifanlimab”) and buffering agents. The disclosure further provides containers and kits comprising such pharmaceutical compositions. The disclosure further provides the use of such pharmaceutical compositions, containers, and kits containing retifanlimab in the treatment of a cancer, and in certain aspects treatment of a cancer expressing PD-L1.

Abstract: A building management system (BMS) for filtering a fluid within a building is shown. The system includes one or more sensors configured to measure one or more characteristics of a first fluid within an air duct of the BMS and measure one or more characteristics of a second fluid after the second fluid has been filtered. The system further includes a pollutant management system configured to receive data from the one or more sensors and control a filtration process. The filtration process selects a filter of a plurality of filters based on at least one of a level of the one or more characteristics of the first fluid or the one or more characteristics of the second fluid.

Abstract: A building management system (BMS) for filtering a fluid within a building is shown. The system includes one or more sensors configured to measure one or more characteristics of a first fluid within an air duct of the BMS and measure one or more characteristics of a second fluid after the second fluid has been filtered. The system further includes a pollutant management system configured to receive data from the one or more sensors and control a filtration process. The filtration process selects a filter of a plurality of filters based on a level of the one or more characteristics of the first fluid and the one or more characteristics of the second fluid.

Abstract: Disclosed are antiseptic compositions for disinfecting tissues, in particular for ocular use. Methods and compositions disclosed herein include sodium chlorite, optionally in combination with a surfactant.

Abstract: Disclosed are antiseptic compositions for disinfecting tissues, in particular for ocular use. Methods and compositions disclosed herein include sodium chlorite, optionally in combination with a surfactant.

Abstract: A leg support apparatus for elevating and exercising an injured leg includes a base. A pair of vertical support legs is coupled to the base. Each support leg has an articulation bracket positioned on a top end thereof. A pair of thigh rods is pivotably coupled to the articulation bracket of the pair of support legs. A gluteal bar and a plurality of thigh straps extend between the thigh rods. A pair of calf rods is pivotably coupled to the articulation bracket. A foot bar extends between a front distal end of each of the foot rods. A plurality of calf straps extends between the calf rods. A pair of pistons is coupled to the pair of support legs and extends to the pair of calf rods to support the pair of calf rods in a horizontal position.